Lalani, Aly-Khan A.
Xie, Wanling
Martini, Dylan J.
Steinharter, John A.
Norton, Craig K.
Krajewski, Katherine M.
Duquette, Audrey
Bossé, Dominick
Bellmunt, Joaquim
Van Allen, Eliezer M.
McGregor, Bradley A.
Creighton, Chad J.
Harshman, Lauren C.
Choueiri, Toni K.
Funding for this research was provided by:
Foundation for the National Institutes of Health (Kidney Spore)
Article History
Received: 2 November 2017
Accepted: 3 January 2018
First Online: 22 January 2018
Authors information
: Not applicable.
: The study was approved by the local institutional review boards and was conducted in accordance with Good Clinical Practice Guidelines and the Declaration of Helskinki.
: Informed consent for publication has been obtained and the consent forms are held by the authors.
: AAL:honoraria/consulting from Novartis; conference travel expenses from Pfizer.WX:honoraria/consulting from Bayer.JB:honoraria/consulting from Astellas, Genentech, Merck, Novartis, Pfizer, Pierre Fabre; institutional research funding/support from Millenium, Sanofi, MSD Oncology, Pfizer.EMVA:honoraria/consulting from Genome Medical, Novartis, Roche, Syapse, Takeda, Third Rock Ventures; institutional research funding/support from Bristol-Myers Squibb, Novartis.BAM:honoraria/consulting from Astellas, Seattle Genetics, Bayer, Astra-Zeneca, Genentech and Exelixis.LCH:honoraria/consulting from Genentech, Pfizer, Dendreon, NCCN, Medivation/Astellas, KEW, Corvus, Merck; institutional research funding/support from Bayer, Medivation/Astellas, Pfizer, Dendreon, Sotio, Genentech, Merck, BMS, Jannsen.TKC: honoraria/consulting from Alligent, AstraZeneca, Bayer, Bristol-Myers Squibb, Cerulean Pharma, Eisai, Exelixis, Foundation Medicine, GlaxoSmithKline, Merck, Novartis, Peloton, Pfizer, Prometheus, Roche/Genentech; institutional research funding/support from Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, Peloton, AstraZeneca, Agensys, TRACON.The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.